2 June 2010 - Press Conference: Official Launch of Rhenovia's Epilepsy Program for the Optimization of Antiepileptic Drug Discovery & Development of Pharmaceutical and Biotechnology Companies.

Press Conference: RHENOVIA PHARMA, Wednesday 2 June 15:15, Maison du Technopole, Mulhouse.

To participate as journalist, please contact urgently Rhenovia at +33 3 89 32 11 80.

We are pleased to invite you to a press conference to mark the official launch of a collaborative project - cluster RHENEPI "Platform of neuronal modeling for the discovery and validation of drug treatments for Epilepsy"

This three-year project, of a total budget of 2.5 million euros, labeled cluster of Drug Innovation Alsace Bio Valley and competitiveness cluster Lyon Biopôle was obtained under the 9th call for projects launched by the Directorate General Competitiveness of Industry and Services of the French Ministry of Economy, Industry and Employment for funding from the Single Interministerial Fund (FUI).

The project RHENEPI lead by Rhenovia Pharma brings together four partners: two industrial partners, Rhenovia, a biotechnology company located in Mulhouse and SynapCell, a biotech company from Grenoble, and two academic partners: the research team of Dr. Antoine Depaulis Grenoble Neurosciences Institute (GIN) and Dr. Laurent Fagni, Institute of Functional Genomics (IGF) in Montpellier.

The project will be launched officially RHENEPI June 2 in the presence of:
- Financial partners of the Ministry of Economy, Industry and Employment, OSEO, the Region Alsace and M2A, Mulhouse Alsace Community
- Partner Alsace Bio Valley Competitiveness Cluster

and the project managers for Rhenovia, SynapCell, GIN and IGF.

We would like to take their presence in Mulhouse, to present you all the partners of the project, its objectives and its medical, societal, economic and scientific repercussions, and particularly the impact of this project for Rhenovia and the Région Alsace.
At the end of an interactive dialogue, we will walk to the new headquarters of Rhenovia (100 m from the Maison du Technopole) to make you discover the new premises of the company and the team of twelve employees at the site of Mulhouse.

We look forward to your involvement in the development of Rhenovia, and we thank you confirm your attendance or that of your colleagues by email.
While waiting to welcome you, please accept, Madam, Sir, our sentiments of respect.